This HTML5 document contains 55 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n18http://localhost/temp/predkladatel/
n14http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n7http://linked.opendata.cz/resource/domain/vavai/projekt/
n19http://linked.opendata.cz/resource/domain/vavai/subjekt/
n12http://linked.opendata.cz/ontology/domain/vavai/
n20http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216224%3A14310%2F13%3A00067961%21RIV14-MSM-14310___/
shttp://schema.org/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/
skoshttp://www.w3.org/2004/02/skos/core#
n13http://bibframe.org/vocab/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n5http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n17http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n11http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216224%3A14310%2F13%3A00067961%21RIV14-MSM-14310___
rdf:type
skos:Concept n12:Vysledek
dcterms:description
Antineoplastic drugs are considered as a potential health risk to healthcare personnel, due to their adverse effects. The objective of the study was to compare the surface contamination level of the conventional preparation room and outpatient clinic before and after the implementation of a set of additional protective measures. To determine the surface contamination level with antineoplastic drugs, cyclophosphamide and platinum were determined in wipe samples with high performance liquid chromatography with tandem mass spectrometry and inductively coupled plasma mass spectrometry.In the preparation room, depending on the sampling spot and analyte, median concentrations ranged from 5 to 267 pg cm(2) and from 2 to 368 pg cm(2) before and after implementation of the measures, respectively. In the outpatient clinic, median concentrations ranged from 5 to 5310 pg cm(2) and from < 0.2 to 574 pg cm(2) before and after implementation of the measures, respectively. Antineoplastic drugs are considered as a potential health risk to healthcare personnel, due to their adverse effects. The objective of the study was to compare the surface contamination level of the conventional preparation room and outpatient clinic before and after the implementation of a set of additional protective measures. To determine the surface contamination level with antineoplastic drugs, cyclophosphamide and platinum were determined in wipe samples with high performance liquid chromatography with tandem mass spectrometry and inductively coupled plasma mass spectrometry.In the preparation room, depending on the sampling spot and analyte, median concentrations ranged from 5 to 267 pg cm(2) and from 2 to 368 pg cm(2) before and after implementation of the measures, respectively. In the outpatient clinic, median concentrations ranged from 5 to 5310 pg cm(2) and from < 0.2 to 574 pg cm(2) before and after implementation of the measures, respectively.
dcterms:title
Evaluation of the Efficacy of Additional Measures Introduced for the Protection of Healthcare Personnel Handling Antineoplastic Drugs Evaluation of the Efficacy of Additional Measures Introduced for the Protection of Healthcare Personnel Handling Antineoplastic Drugs
skos:prefLabel
Evaluation of the Efficacy of Additional Measures Introduced for the Protection of Healthcare Personnel Handling Antineoplastic Drugs Evaluation of the Efficacy of Additional Measures Introduced for the Protection of Healthcare Personnel Handling Antineoplastic Drugs
skos:notation
RIV/00216224:14310/13:00067961!RIV14-MSM-14310___
n12:predkladatel
n19:orjk%3A14310
n4:aktivita
n9:S n9:P
n4:aktivity
P(2B06171), P(ED0001/01/01), P(ED2.1.00/03.0101), P(EE2.3.20.0053), P(LM2011028), S
n4:cisloPeriodika
2
n4:dodaniDat
n11:2014
n4:domaciTvurceVysledku
n14:1297864 n14:4982800 n14:5607442 n14:2218682
n4:druhVysledku
n15:J
n4:duvernostUdaju
n5:S
n4:entitaPredkladatele
n20:predkladatel
n4:idSjednocenehoVysledku
73678
n4:idVysledku
RIV/00216224:14310/13:00067961
n4:jazykVysledku
n17:eng
n4:klicovaSlova
chemical analysis; cytotoxic drugs; hazardous pharmaceuticals; occupational exposure; safety engineering
n4:klicoveSlovo
n8:chemical%20analysis n8:hazardous%20pharmaceuticals n8:cytotoxic%20drugs n8:occupational%20exposure n8:safety%20engineering
n4:kodStatuVydavatele
GB - Spojené království Velké Británie a Severního Irska
n4:kontrolniKodProRIV
[B92A66B172FA]
n4:nazevZdroje
ANNALS OF OCCUPATIONAL HYGIENE
n4:obor
n10:FR
n4:pocetDomacichTvurcuVysledku
4
n4:pocetTvurcuVysledku
6
n4:projekt
n7:LM2011028 n7:EE2.3.20.0053 n7:2B06171 n7:ED2.1.00%2F03.0101 n7:ED0001%2F01%2F01
n4:rokUplatneniVysledku
n11:2013
n4:svazekPeriodika
57
n4:tvurceVysledku
Bláha, Luděk Dolezalova, Lenka Piler, Pavel Oravec, Michal Kuta, Jan Odráška, Pavel
n4:wos
000315158600008
s:issn
0003-4878
s:numberOfPages
11
n13:doi
10.1093/annhyg/mes057
n18:organizacniJednotka
14310